Heartflow Inc

HTFL

24.690USD

-1.190-4.60%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

Heartflow Inc's Score

Industry at a Glance

Industry Ranking

132 / 208

Overall Ranking

345 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Heartflow Inc Highlights

StrengthsRisks

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 101.93% year-on-year.

Undervalued

The company’s latest PE is -7.79, at a low 3-year percentile range.

Held by Steven Cohen

Star Investor Steven Cohen holds 304.49K shares of this stock.

Analyst Rating

Based on 6 analysts

Buy

Current Rating

38.200

Target Price

+36.57%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Heartflow Inc is 7.97, ranking 50 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average.

Score

Industry at a Glance

Previous score

7.97

Change

0



Financials

9.63

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.71

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.68

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.53

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.31

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

No valuation score is currently available for Heartflow Inc. The Healthcare Equipment & Supplies industry's average is 7.17. Its current P/E ratio is -7.79, which is -46.06% below the recent high of -4.20 and -12.39% above the recent low of -8.76.

Score

Industry at a Glance

Previous score

0.00

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 132/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Heartflow Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 40.00, with a high of 40.00 and a low of 35.00.

Score

Industry at a Glance

Previous score

8.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Heartflow Inc is 4.63, ranking 187 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 28.98 and the support level at 20.41, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.69

Change

-0.06

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

Score

Industry at a Glance

Previous score

3.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Wellington Management Company, LLP

4.88M

+10.55%

Bain Capital Life Sciences Investors, LLC

12.45M

--

HealthCor Partners Management LP

6.70M

--

Fidelity Management & Research Company LLC

4.62M

+40.42%

Hayfin Capital Management LLP

3.64M

-0.00%

Baillie Gifford & Co.

Star Investors

3.01M

+16.06%

Baron Capital Management, Inc.

Star Investors

1.24M

--

Schusterman Interests LLC

1.94M

--

Capricorn Investment Group LLC

3.92M

--

The Vanguard Group, Inc.

Star Investors

1.45M

+24.45%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Heartflow Inc is 4.14, ranking 109 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Heartflow Inc

HTFL

5.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment